Loading clinical trials...
Loading clinical trials...
An International Multicentre Randomized Unblinded Phase II Study Comparing Adjuvant Treatment With 177Lu-DOTATATE (Lutathera®) to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases
Conditions
Interventions
Lutathera
Locations
1
United Kingdom
Imperial College Healthcare NHS Trust
London, United Kingdom
Start Date
August 2, 2024
Primary Completion Date
October 21, 2025
Completion Date
October 21, 2025
Last Updated
January 14, 2026
NCT03206060
NCT05636618
NCT07536087
NCT06228066
NCT05746208
NCT07129252
Lead Sponsor
Imperial College London
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions